Local absorption kinetics of levofloxacin from intestinal tract into portal vein in conscious rat using portal-venous concentration difference

被引:26
作者
Fujieda, Y [1 ]
Yamaoka, K [1 ]
Ito, T [1 ]
Nakagawa, T [1 ]
机构
[1] KYOTO UNIV,FAC PHARMACEUT SCI,SAKYO KU,KYOTO 606,JAPAN
关键词
levofloxacin; portal-venous blood concentration difference; first-pass effects; electromagnetic blood flow meter;
D O I
10.1023/A:1016012203496
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The local absorption kinetics of levofloxacin from the intestinal tract was quantitatively evaluated by simultaneously measuring the portal and venous plasma concentrations in a conscious rat. Methods, The venous and upper portal blood vessels were cannulated through the jugular and pyloric veins, respectively. After oral or intravenous administration of levofloxacin, portal and venous concentrations of levofloxacin were simultaneously monitored. The absorption rate from the intestine into the portal system was calculated from the portal-venous difference in the plasma concentration of levofloxacin, considering the distribution of levofloxacin into erythrocytes. Portal blood flow rate was newly measured by an electromagnetic flow meter. Results, There was little portal-venous difference after an intravenous dose of levofloxacin. In contrast, after oral administration, the plasma concentration in the portal vein was constantly higher than that in the jugular vein, demonstrating that this difference was caused by the intestinal absorption of levofloxacin. Conclusions, Approximately 90% levofloxacin was absorbed as the intact form from the intestinal tract into the portal system. By considering the bioavailability of levofloxacin in rat, the hepatic extraction ratio in vivo of levofloxacin was estimated to be 30%. The mean local absorption time (<(t)over bar (a)>) was 1.44hr which coincided almost with the mean absorption time (MAT).
引用
收藏
页码:1201 / 1204
页数:4
相关论文
共 15 条
[1]  
DAEMEN MJA, 1988, J PHARMACOL METHOD, V21, P287
[2]   LEVOFLOXACIN A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETICS AND THERAPEUTIC EFFICACY [J].
DAVIS, R ;
BRYSON, HM .
DRUGS, 1994, 47 (04) :677-700
[3]   INVITRO AND INVIVO ANTIBACTERIAL ACTIVITIES OF LEVOFLOXACIN (L-OFLOXACIN), AN OPTICALLY-ACTIVE OFLOXACIN [J].
FU, KP ;
LAFREDO, SC ;
FOLENO, B ;
ISAACSON, DM ;
BARRETT, JF ;
TOBIA, AJ ;
ROSENTHALE, ME .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (04) :860-866
[4]   PHARMACOKINETICS AND SAFETY OF LEVOFLOXACIN IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
GOODWIN, SD ;
GALLIS, HA ;
CHOW, AT ;
WONG, FA ;
FLOR, SC ;
BARTLETT, JA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (04) :799-804
[5]  
HADENGUE A, 1988, P SOC EXP BIOL MED, V187, P461
[6]   METHOD TO ESTIMATE THE RATE AND EXTENT OF INTESTINAL-ABSORPTION IN CONSCIOUS RATS USING AN ABSORPTION PROBE AND PORTAL BLOOD-SAMPLING [J].
HOFFMAN, DJ ;
SEIFERT, T ;
BORRE, A ;
NELLANS, HN .
PHARMACEUTICAL RESEARCH, 1995, 12 (06) :889-894
[7]   OFLOXACIN CLINICAL PHARMACOKINETICS [J].
LAMP, KC ;
BAILEY, EM ;
RYBAK, MJ .
CLINICAL PHARMACOKINETICS, 1992, 22 (01) :32-46
[8]   PHYSIOLOGICAL PHARMACOKINETICS OF ETHOXYBENZAMIDE BASED ON BIOCHEMICAL DATA OBTAINED INVITRO AS WELL AS ON PHYSIOLOGICAL DATA [J].
LIN, JH ;
SUGIYAMA, Y ;
AWAZU, S ;
HANANO, M .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1982, 10 (06) :649-661
[9]   PHARMACOKINETICS OF OFLOXACIN AFTER PARENTERAL AND ORAL-ADMINISTRATION [J].
LODE, H ;
HOFFKEN, G ;
OLSCHEWSKI, P ;
SIEVERS, B ;
KIRCH, A ;
BORNER, K ;
KOEPPE, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (09) :1338-1342
[10]   STEREOSELECTIVE METABOLIC DISPOSITION OF ENANTIOMERS OF OFLOXACIN IN RATS [J].
OKAZAKI, O ;
KURATA, T ;
TACHIZAWA, H .
XENOBIOTICA, 1989, 19 (04) :419-429